Pharmacokinetics of Fidaxomicin Completed Phase 1 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0062646 (Pharmacokinetics of Fidaxomicin)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02083627A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male SubjectsBasic Science